Activating Treatment as Prevention Through Community Mobilization in South Africa

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT02197793
Collaborator
University of Witwatersrand, South Africa (Other), University of North Carolina, Chapel Hill (Other)
2,338
1
2
53
44.1

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the impact of a community mobilization intervention on the uptake of HIV testing, linkage to and retention in HIV care using a community, cluster randomized trial.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Community Mobilization Program
N/A

Detailed Description

Eight of 16 intervention naïve communities in the Agincourt HDSS will be randomized to receive the CM intervention to activate TasP based on the investigators CM conceptual framework. The 16 villages will be randomized based on the "restricted randomization" approach, a stratification method to ensure overall balance between intervention and control communities.

Intervention activities will map onto the investigators six mobilization domains identified in the investigators preliminary work as key components for communities to mobilize for change around HIV prevention. These activities will support communities to: 1) identify a shared concern around testing, linkage and retention in care; 2) enable communities to develop critical consciousness around TasP; 3) facilitate identification and development of structures and networks to disseminate information and activities around TasP; 4) identify and engage community leadership around TasP; 5) take collection action to support TasP; and 6) build community cohesion to address the HIV epidemic and support access to care.

The investigators will evaluate the impact of the intervention using a linked data set including electronic clinic records and the HDSS census data, which will allow us to determine whether people in the intervention communities test at higher proportions than those in control communities, whether individuals who test positive in the intervention communities are more likely to receive CD4 testing and initiate treatment within 3 months than the control communities, and whether those who are eligible and not eligible for treatment are retained in care.

The investigators will implement a representative cross-sectional survey in all 16 villages prior to and following the intervention in order to examine changes in CM domains across villages and the mechanisms through which the intervention affects HIV testing, linkage and retention.

In addition, intervention progress and dosage will be carefully monitored through a tracking system to document all workshops and activities that are carried out in each village.

Study Design

Study Type:
Interventional
Actual Enrollment :
2338 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Activating Treatment as Prevention Through Community Mobilization in South Africa
Actual Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Community Mobilization Program

Intervention activities will map onto six mobilization domains identified as key components for communities to mobilize for change around testing, linkage and retention in care (Treatment as Prevention (TasP)).

Behavioral: Community Mobilization Program

No Intervention: Control Arm

The control arm does not receive the Community Mobilization Intervention.

Outcome Measures

Primary Outcome Measures

  1. Rates of HIV Testing [3 years follow-up]

    Tested /Untested past 12 mos, among HIV-negative or unknown status residents

  2. Rates of linkage to care CD4 within 3 months [3 years follow-up]

    Received CD4 results or had clinical visit within 3 mos of testing HIV positive among recent positives

  3. Rates of retention in care [3 years follow-up]

    No treatment default (no more than a 90-day gap in medication or visit schedule)

Secondary Outcome Measures

  1. Median CD4 of people initiating ART [3 years follow-up]

    Median CD4 at entry into care

  2. Re-engagement in care [3 years follow-up]

    Patients out of care for ≥ 12 months who are re-engaged in care, as evidenced by a clinical visit or CD4 test

  3. Testing Yield [3 years follow-up]

    Number of new diagnoses

  4. First Time Testers [3 years follow-up]

    Number of first time testers (in particular the number of HIV infected undiagnosed)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • lived in the study area for 12 months

  • age 18-49 years

  • able to provide informed consent.

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 MRC/Wits Rural Public Health and Heath Transitions Research Unit Agincourt Mpumalanga South Africa

Sponsors and Collaborators

  • University of California, San Francisco
  • University of Witwatersrand, South Africa
  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Audrey Pettifor, PhD, University of North Carolina, Chapel Hill

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT02197793
Other Study ID Numbers:
  • 14-13575
First Posted:
Jul 23, 2014
Last Update Posted:
Sep 9, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No

Study Results

No Results Posted as of Sep 9, 2020